CoChat
Sign Up
Cited by 181Immune cells in cancerNF-κB Signaling PathwaysInflammatory mediators and NSAID effects

Molecular pathways in cancer-related inflammation

Open access
Del Prete, Annalisa, Allavena, Paola, Santoro, Giuseppe, Fumarulo, Ruggiero, Corsi, Massimiliano M., Mantovani, Alberto·2011·Biochemia Medica
DOI 10.11613/bm.2011.036
Open this paper in CoChat — free accountOpen PDF

Abstract

Ac cu mu la ti ng evi den ce shows that chro nic in fl am ma tion is as so cia ted to in crea sed ri sk of can cer.An in fl am ma to ry com po ne nt is pre se nt al so in the mic roen vi ron me nt of tu mou rs epi de mio lo gi cal ly un re la ted to in fl am ma tion.Exten si ve in ves ti ga tio ns over the pa st de ca de ha ve un co ve red ma ny of the im por ta nt mec ha nis tic pat hways un der lyi ng can ce r-re la ted in fl am ma tion.Pat hways lin ki ng in fl am ma tion and can cer ha ve been iden ti fi ed: an in trin sic one (dri ven by ge ne tic even ts that cau se neop la sia) and an extrin sic one (dri ven by in fl am ma to ry con di tio ns whi ch pre dis po se to can cer).Smoul de ri ng in fl am ma tion is a com po ne nt of the tu mour mic roen vi ron me nt and is a re cog ni zed hal lma rk of can cer.Key or ches tra to rs at the in tersec tion of the in trin sic and extrin sic pat hways in clu de tran scrip tion fac to rs (e.g.Nuc lear Fac tor kap pa-B, NFκB) that mo du la te the in fl am ma to ry res pon se throu gh so lub le me dia to rs (cyto ki nes, che mo ki nes) and cel lu lar com po nen ts (e.g.tu mo r-as so cia ted mac rop ha ges), pro mo ti ng tu mo ri gene sis.NFκB aids in the pro li fe ra tion and sur vi val of ma lig na nt cel ls, pro mo tes an gio ge ne sis and me tas ta sis, sub ver ts adap ti ve im mu ni ty, and al te rs res pon ses to hor mo nes and che mot he ra peu tic agen ts.Emer gi ng evi den ce al so sug ges ts that per sis te nt in fl am ma tion pro mo tes ge ne tic in sta bi li ty.Thus, can ce r-re la ted in fl am ma tion rep re sen ts a tar get for in no va ti ve diag nos tic and the ra peu tic stra te gies.Key wor ds: can ce r-re la ted in fl am ma tion; cyto ki nes; che mo ki nes; mac rop ha ges

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.11613/bm.2011.036

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 22 · Cited by 181

Part of this paper’s reference list could not be split into single entries.

Research works printed but not linked: 98

  1. Bal kwi ll F, Man to va ni A. In fl am ma tion and can cer: ba ck to Vir chow? Lan cet 2001;357:539-5.
  2. Man to va ni A, Al la ve na P, Si ca A, Bal kwi ll F. Can ce r-re la ted in fl am ma tion. Na tu re 2008;454:436-4.
  3. Man to va ni A, Gar lan da C, Al la ve na P. Mo le cu lar pat hways and tar ge ts in can ce r-re la ted in fl am ma tion. Ann Med 2010;42:161-70.
  4. Rot hwe ll PM, Fowkes FG, Bel ch JF, Ogawa H, War low CP, Mea de TW. Eff e ct of dai ly as pi rin on lo ng-te rm ri sk of dea th due to can cer: ana lysis of in di vi dual pa tie nt da ta from ran- do mi sed tria ls. Lan cet 2011;377:31-41.
  5. Men ter DG, Schil sky RL, Du Bois RN. Cyclooxyge na se-2 and can cer treat me nt: un der stan di ng the ri sk shou ld be wor th the rewa rd. Clin Can cer Res 2010;16:1384-90.
  6. Van nuc ci L, Ste pan ko va R, Gro ba ro va V, Ko za ko va H, Ros- sma nn P, Kli me so va K, et al. Co lo rec tal car ci no ma: Im por- tan ce of co lo nic en vi ron me nt for an ti-can cer res pon se and syste mic im mu ni ty. J Im mu no toxi col 2009;6:217-26.
  7. Rius J, Gu ma M, Schac htrup C, Akas sog lou K, Zin ker na gel AS, Ni zet V, et al. NF-kappaB lin ks in na te im mu ni ty to the hypoxic res pon se throu gh tran scrip tio nal re gu la tion of HI- F-1al pha. Na tu re 2008;453:807-11.
  8. Yu H, Par do ll D, Jo ve R. STA Ts in can cer in fl am ma tion and im mu ni ty: a lea di ng ro le for STA T3. Nat Rev Can cer 2009;9:798-09.
  9. Al la ve na P, Ger ma no G, Mar che si F, Man to va ni A. Che- mo ki nes in can cer re la ted in fl am ma tion. Exp Ce ll Res 2011;317:664-73.
  10. Man to va ni A. Can cer: In fl a mi ng me tas ta sis. Na tu re 2009;457:36-7.
  11. Hana han D, Wein be rg RA. Hal lmar ks of can cer: the next ge ne ra tion. Ce ll 2011;144:646-74.
  12. Bor rel lo MG, Al ber ti L, Fis cher A, Deg l'in no cen ti D, Fer ra rio C, Ga ri bol di M, et al. In duc tion of a proin fl am ma to ry prog- ram in nor mal hu man thyro cytes by the RET/PTC1 on co ge- ne. Proc Na tl Acad Sci U S A 2005;102:14825-30.
  13. Rus se ll JP, En gi les JB, Rot hstein JL. Proin fl am ma to ry me dia- to rs and ge ne tic bac kgrou nd in on co ge ne me dia ted tu mor prog res sion. J Im mu nol 2004;172:4059-67.
  14. Rus se ll JP, Shi no ha ra S, Me lil lo RM, Cas tel lo ne MD, San to- ro M, Rot hstein JL. Tyro si ne ki na se on cop ro tein, RET/PTC3, in du ces the sec re tion of mye loid growth and che mo tac tic fac to rs. On co ge ne 2003;22:4569-77.
  15. Ce rut ti JM, OlerG, Mic ha lua rt P, Del ce lo R, Bea ty RM, Shoe- ma ker J, Rig gi ns GJ. Mo le cu lar pro fi li ng of mat ched sam- ples iden ti fi es bio mar ke rs of pa pil la ry thyroid car ci no ma lymph no de me tas ta sis. Can cer Res 2007;67:7885-92.
  16. De Fal co V, Gua ri no V, Avil la E, Cas tel lo ne MD, Sa ler no P, Sal va to re G, et al. Bio lo gi cal ro le and po ten tial the ra peu tic tar ge ti ng of the che mo ki ne re cep tor CXCR4 in un diff e ren- tia ted thyroid can cer. Can cer Res 2007;67:11821-9.
  17. Xu K, Shu HK. EGFR ac ti va tion re sul ts in en han ced cyclooxyge na se-2 expres sion throu gh p38 mi to ge n-ac- ti va ted pro tein ki na se-de pen de nt ac ti va tion of the Sp1/ Sp3 tran scrip tion fac to rs in hu man glio mas. Can cer Res 2007;67:6121-9.
  18. Ma si h-Khan E, Tru del S, Hei se C, Li Z, Pa ter son J, Na deem V, et al. MI P-1al pha (CCL3) is a downstream tar get of FG- FR3 and RAS-MAPK sig na li ng in mul tip le mye lo ma. Blood 2006;108:3465-71.
  19. Wa ng D, Wa ng H, Brown J, Dai ko ku T, Ni ng W, Shi Q, et al. CXCL1 in du ced by pros tag lan din E2 pro mo tes an gio ge ne- sis in co lo rec tal can cer. J Exp Med 2006;203:941-51.
  20. Guer ra C, Schuh mac her AJ, Ca na me ro M, Grip po PJ, Ver da- guer L, Pe re z-Gal le go L, et al. Chro nic pan crea ti tis is es sen- tial for in duc tion of pan crea tic duc tal ade no car ci no ma by K- Ras on co ge nes in adu lt mi ce. Can cer Ce ll 2007;11:291-02.
  21. Su mi mo to H, Ima bayas hi F, Iwa ta T, Kawa ka mi Y. The BRAF-MAPK sig na li ng pat hway is es sen tial for can ce- r-im mu ne eva sion in hu man me la no ma cel ls. J Exp Med 2006;203:1651-6.
  22. Sou cek L, Lawlor ER, So to D, Shcho rs K, Swi ga rt LB, Evan GI. Ma st cel ls are requi red for an gio ge ne sis and mac ros co- pic expan sion of Myc-in du ced pan crea tic is let tu mo rs. Nat Med 2007;13:1211-8.
  23. Bal kwi ll F, Char les KA, Man to va ni A. Smol de ri ng and po la- ri zed in fl am ma tion in the ini tia tion and pro mo tion of ma- lig na nt di sea se. Can cer Ce ll 2005;7:211-7.
  24. Bie rie B, Mo ses HL. TGF-be ta and can cer. Cyto ki ne Growth Fac tor Rev 2006;17:29-40.
  25. Ya ng L, Hua ng J, Ren X, Gor ska AE, Chytil A, Aak re M, et al. Ab ro ga tion of TGF be ta sig na li ng in mam ma ry car ci no mas rec rui ts Gr-1+CD11b+ mye loid cel ls that pro mo te me tas ta- sis. Can cer Ce ll 2008;13:23-35.
  26. Ko bie lak A, Fuc hs E. Lin ks be tween al pha-ca te nin, NF-kap- paB, and squa mous ce ll car ci no ma in skin. Proc Na tl Acad Sci U S A 2006;103:2322-7.
  27. Rol ny C, Cap pa ruc cia L, Ca saz za A, Maz zo ne M, Val la- rio A, Cig net ti A, et al. The tu mor sup pres sor se map ho- rin 3B trig ge rs a pro me tas ta tic prog ram me dia ted by in- ter leu kin 8 and the tu mor mic roen vi ron me nt. J Exp Med 2008;205:1155-71.
  28. Mos ko vi ts N, Ka lin ko vi ch A, Bar J, La pi dot T, Oren M. p53 At te nua tes can cer ce ll mig ra tion and in va sion throu gh rep- res sion of SDF-1/CXCL12 expres sion in stro mal fi b rob las ts. Can cer Res 2006;66:10671-6.
  29. Ka mp DW, Shac ter E, Weit zman SA. Chro nic in fl am ma tion and can cer: the ro le of the mi toc hon dria. On co lo gy (Wil lis- ton Pa rk) 2011;25:400-13.
  30. Fer ro ne C, Dra no ff G. Dual ro les for im mu ni ty in gas troin- tes ti nal can ce rs. J Clin On col 2010;28:4045-51.
  31. Po pi va no va BK, Ki ta mu ra K, Wu Y, Kon do T, Ka gaya T, Ka- ne ko S, et al. Bloc ki ng TNF-al pha in mi ce re du ces co lo rec tal car ci no ge ne sis as so cia ted wi th chro nic co li tis. J Clin In ve st 2008;118:560-70.
  32. Gol dko rn T, Fi los to S. Lu ng inju ry and can cer: Mec ha nis tic in sig hts in to ce ra mi de and EGFR sig na li ng un der ci ga ret te smo ke. Am J Res pir Ce ll Mol Biol 2010;43:259-68.
  33. Yao H, Rah man I. Cur re nt con cep ts on the ro le of in fl am- ma tion in COPD and lu ng can cer. Cu rr Opin Phar ma col 2009;9:375-83.
  34. Wein be rg F, Ha ma na ka R, Whea ton WW, Wein be rg S, Jo- se ph J, Lo pez M, et al. Mi toc hon drial me ta bo li sm and ROS ge ne ra tion are es sen tial for Kra s-me dia ted tu mo ri ge ni ci ty. Proc Na tl Acad Sci U S A 2010;107:8788-93.
  35. Naik E, Dixit VM. Mi toc hon drial reac ti ve oxygen spe cies dri ve proin fl am ma to ry cyto ki ne pro duc tion. J Exp Med 2011;208:417-20.
  36. Zhou R, Yaz di AS, Me nu P, Tscho pp J. A ro le for mi toc- hon dria in NLR P3 in fl am ma so me ac ti va tion. Na tu re 2011;469:221-5.
  37. Ral ph SJ, Rod ri gue z-En riquez S, Neu zil J, Saa ved ra E, Mo- re no-San chez R. The cau ses of can cer re vi si ted: "mi toc hon- drial ma lig nan cy" and RO S-in du ced on co ge nic tran sfor- ma tion -why mi toc hon dria are tar ge ts for can cer the ra py. Mol As pec ts Med 2010;31:145-70.
  38. Mat su mo to Y, Ma ru sawa H, Ki nos hi ta K, En do Y, Kou T, Mo- ri sawa T, et al. He li co bac ter pylo ri in fec tion trig ge rs aber ra- nt expres sion of ac ti va tio n-in du ced cyti di ne dea mi na se in gas tric epit he lium. Nat Med 2007;13:470-6.
  39. Ko mo ri J, Ma ru sawa H, Mac hi mo to T, En do Y, Ki nos hi ta K, Kou T, et al. Ac ti va tio n-in du ced cyti di ne dea mi na se lin ks bi- le du ct in fl am ma tion to hu man cho lan gio car ci no ma. He- pa to lo gy 2008;47:888-96.
  40. Ka rin M. Nuc lear fac to r-kap paB in can cer de ve lop me nt and prog res sion. Na tu re 2006;441:431-6.
  41. Vo ro nov E, Shou val DS, Kre lin Y, Cag na no E, Ben har ro ch D, Iwa ku ra Y, et al. IL-1 is requi red for tu mor in va si ve ne ss and an gio ge ne sis. Proc Na tl Acad Sci USA 2003;100:2645-50.
  42. Lan gowski JL, Zha ng X, Wu L, Mat tson JD, Chen T, Smi th K, et al. IL-23 pro mo tes tu mour in ci den ce and growth. Na tu re 2006;442:461-5.
  43. Pi kar sky E, Po rat RM, Stein I, Ab ra mo vit ch R, Amit S, Ka sem S, et al. NF-kappaB fun ctio ns as a tu mour pro mo ter in in- fl am ma tio n-as so cia ted can cer. Na tu re 2004;431:461-6.
  44. Sa ka mo to K, Hi ki ba Y, Na ka gawa H, Haya kawa Y, Ya nai A, Aka nu ma M, et al. In hi bi tor of kap paB ki na se be ta re gu la- tes gas tric car ci no ge ne sis via in ter leu ki n-1al pha expres- sion. Gas troen te ro lo gy 2010;139:226-38.
  45. Car bia-Na gas hi ma A, Ge rez J, Pe re z-Cas tro C, Pae z-Pe re da M, Sil ber stein S, Stal la GK, et al. RSUME, a sma ll RWD-con- tai ni ng pro tein, en han ces SUMO co nju ga tion and sta bi li- zes HI F-1al pha du ri ng hypoxia. Ce ll 2007;131:309-23.
  46. Ju ng YJ, Isaa cs JS, Lee S, Tre pel J, Nec ke rs L. IL-1be ta-me dia- ted up-re gu la tion of HI F-1al pha via an NFkappaB/COX-2 pat hway iden ti fi es HI F-1 as a cri ti cal li nk be tween in fl am- ma tion and on co ge ne sis. FASEB J 2003;17:2115-7.
  47. Gar lan da C, Ri va F, Ve liz T, Po len ta rut ti N, Pa squa li ni F, Ra- dael li E, et al. In crea sed sus cep ti bi li ty to co li ti s-as so cia ted can cer of mi ce lac ki ng TI R8, an in hi bi to ry mem ber of the in ter leu ki n-1 re cep tor fa mi ly. Can cer Res 2007; 67:6017-21.
  48. Xiao H, Gu len F, Qin J, Yao J, Bu lek K, Ki sh D, et al. The To- ll-in ter leu ki n-1 re cep tor mem ber SIGIRR re gu la tes co lo nic epit he lial ho meos ta sis, in fl am ma tion, and tu mo ri ge ne sis. Im mu ni ty 2007;26:461-75.
  49. Le ch M, Kul kar ni OP, Pfeiff er S, Sa va re se E, Krug A, Gar lan- da C, et al. Ti r8/Sigirr pre ven ts mu ri ne lu pus by sup pres si- ng the im mu nos ti mu la to ry eff ec ts of lu pus au toan ti ge ns. J Exp Med 2008;205:1879-88.
  50. Ber ti lac cio MT, Si mo net ti G, Dag klis A, Roc chi M, Ve liz Rod- ri guez T, Apol lo nio B, et al. La ck of TI R8/SIGIRR trig ge rs prog res sion of chro nic lympho cytic leu ke mia in mou se mo- de ls. Blood 2011; 118:660-9.
  51. Ver stre pen L, Ver hel st K, van Loo G, Car pen tier I, Ley SC, Beyae rt R. Expres sion, bio lo gi cal ac ti vi ties and mec ha nis ms of ac tion of A20 (TNFAI P3). Bioc hem Phar ma col 2010;80:2009-20.
  52. Bi swas SK, Gan gi L, Paul S, Schiop pa T, Sac ca ni A, Si ro- ni M, et al. A dis tin ct and unique tran scrip tio nal prog ram expres sed by tu mo r-as so cia ted mac rop ha ges (de fec ti ve NF-kappaB and en han ced I R F-3/STAT1 ac ti va tion). Blood 2006;107:2112-22.
  53. Si ca A. Ro le of tu mou r-as so cia ted mac rop ha ges in can ce r- re la ted in fl am ma tion. Exp On col 2010;32:153-8.
  54. Ha ge ma nn T, Lawren ce T, McNei sh I, Char les KA, Kul- be H, Thom pson RG, et al. "Re-e du ca ti ng" tu mo r-as so- cia ted mac rop ha ges by tar ge ti ng NF-kappaB. J Exp Med 2008;205:1261-8.
  55. Kor tylewski M, Ku jawski M, Wa ng T, Wei S, Zha ng S, Pi lo n- Tho mas S, et al. In hi bi ti ng Sta t3 sig na li ng in the he ma to- poie tic system eli ci ts mul ti com po ne nt an ti tu mor im mu ni- ty. Nat Med 2005;11:1314-21.
  56. Moo re RJ, Owe ns DM, Sta mp G, Ar no tt C, Bur ke F, Ea st N, et al. Mi ce de fi cie nt in tu mor nec ro sis fac to r-al pha are re sis ta- nt to skin car ci no ge ne sis. Nat Med 1999;5:828-31.
  57. Bal kwi ll F. Tu mour nec ro sis fac tor and can cer. Nat Rev Can- cer 2009;9:361-71.
  58. Ha ge ma nn T, Wil son J, Kul be H, Li NF, Lein ster DA, Char les K, et al. Mac rop ha ges in du ce in va si ve ne ss of epit he lial can cer cel ls via NF-kap pa B and JNK. J Im mu nol 2005;175:1197-05.
  59. Char les KA, Kul be H, So per R, Es cor cio-Cor reia M, Lawren ce T, Schul theis A, et al. The tu mo r-pro mo ti ng ac tio ns of TNF- al pha in vol ve TNFR1 and IL-17 in ova rian can cer in mi ce and hu ma ns. J Clin In ve st 2009;119:3011-23.
  60. Kul be H, Thom pson R, Wil son JL, Ro bin son S, Ha ge ma nn T, Fa tah R, et al. The in fl am ma to ry cyto ki ne tu mor nec ro- sis fac to r-al pha ge ne ra tes an au toc ri ne tu mo r-pro mo ti- ng ne two rk in epit he lial ova rian can cer cel ls. Can cer Res 2007;67:585-92.
  61. Man to va ni A, Soz za ni S, Lo ca ti M, Al la ve na P, Si ca A. Mac- rop ha ge po la ri za tion: tu mo r-as so cia ted mac rop ha ges as a pa ra di gm for po la ri zed M2 mo no nuc lear pha go cytes. Tren ds Im mu nol 2002;23:549-55.
  62. Si ca A, Schiop pa T, Man to va ni A, Al la ve na A. Tu mou r-as- so cia ted mac rop ha ges are a dis tin ct M2 po la ri sed po pu- la tion pro mo ti ng tu mour prog res sion: po ten tial tar ge ts of an ti-can cer the ra py. Eur J Can cer 2006;42:717-27.
  63. Ogu ma K, Os hi ma H, Ao ki M, Uc hio R, Na ka K, Na ka mu- ra S, et al. Ac ti va ted mac rop ha ges pro mo te Wnt sig nal li- ng throu gh tu mour nec ro sis fac to r-al pha in gas tric tu mour cel ls. EMBO J 2008;27:1671-81.
  64. Har ri son ML, Ober muel ler E, Mai sey NR, Hoa re S, Ed mon- ds K, Li NF, et al. Tu mor nec ro sis fac tor al pha as a new tar- get for re nal ce ll car ci no ma: two sequen tial pha se II tria- ls of in fl ixi mab at stan da rd and hi gh do se. J Clin On col 2007;25:4542-9.
  65. Cha ng YC, Chen TC, Lee CT, Ya ng CY, Wa ng HW, Wa ng CC, Hsieh SL. Epi ge ne tic con trol of MHC cla ss II expres sion in tu- mo r-as so cia ted mac rop ha ges by de coy re cep tor 3. Blood 2008;111:5054-63.
  66. Gia vaz zi R, Ga ro fa lo A, Ba ni MR, Ab ba te M, Ghez zi P, Bo ras- chi D, et al. In ter leu kin 1-induced aug men ta tion of expe ri- men tal me tas ta ses from a hu man me la no ma in nu de mi- ce. Can cer Res 1990;50:4771-5.
  67. Luo JL, Tan W, Ri co no JM, Kor chynskyi O, Zha ng M, Go- nias SL, et al. Nuc lear cyto ki ne-ac ti va ted IK Kal pha con tro- ls pros ta te can cer me tas ta sis by rep res si ng Mas pin. Na tu re 2007;446:690-4.
  68. Wycko ff JB, Wa ng Y, Lin EY, Li JF, Go swa mi S, Stan ley ER, et al. Di re ct vi sua li za tion of mac rop ha ge-as sis ted tu- mor ce ll in tra va sa tion in mam ma ry tu mo rs. Can cer Res 2007;67:2649-56.
  69. Man to va ni A, Schiop pa T, Por ta C, Al la ve na P, Si ca A. Ro- le of tu mo r-as so cia ted mac rop ha ges in tu mor prog res sion and in va sion. Can cer Me tas ta sis Rev 2006;25:315-22.
  70. Con dee lis J, Pol la rd JW. Mac rop ha ges: ob li ga te par tne- rs for tu mor ce ll mig ra tion, in va sion, and me tas ta sis. Ce ll 2006;124:263-6.
  71. Kim S, Ta ka has hi H, Lin WW, Des car gues P, Gri ven ni kov S, Luo JL, et al. Car ci no ma-pro du ced fac to rs ac ti va te mye- loid cel ls throu gh TLR2 to sti mu la te me tas ta sis. Na tu re 2009;457:102-6.
  72. Nal di ni A, Fi lip pi I, Mig liet ta D, Mos chet ta M, Gia vaz zi R, Car ra ro F. In ter leu ki n-1be ta re gu la tes the mig ra to ry po ten- tial of MDAM B231 brea st can cer cel ls throu gh the hypoxia- in du cib le fac to r-1al pha. Eur J Can cer 2010;46:3400-8.
  73. Di na rel lo CA. The pa ra dox of pro-in fl am ma to ry cyto ki nes in can cer. Can cer Me tas ta sis Rev 2006;25:307-13.
  74. Ar guel lo F, Bag gs RB, Gra ves BT, Ha rwe ll SE, Co hen HJ, Fran- tz CN. Eff e ct of IL-1 on expe ri men tal bo ne/bone-marrow me tas ta ses. Int J Can cer 1992;52:802-7.
  75. Car mi Y, Vo ro nov E, Do tan S, La hat N, Ra hat MA, Fo gel M, et al. The ro le of mac rop ha ge-de ri ved IL-1 in in duc tion and main te nan ce of an gio ge ne sis. J Im mu nol 2009;183:4705-14.
  76. Shcho rs K, Shcho rs E, Ros tker F, Lawlor ER, Brown-Swi ga rt L, Evan GI. The Myc-de pen de nt an gio ge nic swit ch in tu mo rs is me dia ted by in ter leu kin 1beta. Ge nes Dev 2006;20:2527- 38.
  77. Sa ku rai T, He G, Mat su zawa A, Yu GY, Mae da S, Har di man G, Ka rin M. He pa to cyte nec ro sis in du ced by oxi da ti ve stre ss and IL-1 al pha re lea se me dia te car ci no ge n-in du ced com- pen sa to ry pro li fe ra tion and li ver tu mo ri ge ne sis. Can cer Ce- ll 2008;14:156-65.
  78. Mar ha ba R, Na za ren ko I, Knofl er D, Rei ch E, Vo ro nov E, Vi- ta co lon na M, et al. Op po si ng eff ec ts of fi b ro sar co ma ce ll- de ri ved IL-1 al pha and IL-1 be ta on im mu ne res pon se in- duc tion. Int J Can cer 2008;123:134-45.
  79. El ka be ts M, Kre lin Y, Do tan S, Ce rwen ka A, Por ga dor A, Lic- hten stein RG, et al. Ho st-de ri ved in ter leu ki n-1al pha is im- por ta nt in de ter mi ni ng the im mu no ge ni ci ty of 3-methylc- holantrene tu mor cel ls. J Im mu nol 2009;182:4874-81.
  80. Chen CJ, Ko no H, Go len bo ck D, Reed G, Aki ra S, Ro ck KL. Iden ti fi ca tion of a key pat hway requi red for the ste ri le in- fl am ma to ry res pon se trig ge red by dyi ng cel ls. Nat Med 2007;13:851-6.
  81. Chi ri vi RG, Ga ro fa lo A, Pa du ra IM, Man to va ni A, Gia vaz zi R. In ter leu kin 1 re cep tor an ta go ni st in hi bi ts the aug men ta- tion of me tas ta sis in du ced by in ter leu kin 1 or li po po lysac- cha ri de in a hu man me la no ma/nude mou se system. Can- cer Res 1993;53:5051-4.
  82. Vi da l-Va nac loc ha F, Ame za ga C, Asu men di A, Kap lan ski G, Di na rel lo CA. Inter leu ki n-1 re cep tor bloc ka de re du ces the num ber and si ze of mu ri ne B16 me la no ma he pa tic me tas- ta ses. Can cer Res 1994;54:2667-72.
  83. Lu st JA, La cy MQ, Zel den ru st SR, Dis pen zie ri A, Ger tz MA, Wit zig TE, et al. In duc tion of a chro nic di sea se sta te in pa- tien ts wi th smol de ri ng or in do le nt mul tip le mye lo ma by tar ge ti ng in ter leu kin 1{beta}-induced in ter leu kin 6 pro duc- tion and the mye lo ma pro li fe ra ti ve com po ne nt. Mayo Clin Proc 2009;84:114-22.
  84. Di na rel lo CA. Why not treat hu man can cer wi th in ter leu ki- n-1 bloc ka de? Can cer Me tas ta sis Rev 2010;29:317-29.
  85. Lin WW, Ka rin M. A cyto ki ne-me dia ted li nk be tween in- na te im mu ni ty, in fl am ma tion, and can cer. J Clin In ve st 2007;117:1175-83.
  86. Naug ler WE, Ka rin M. The wo lf in shee p's clot hi ng: the ro- le of in ter leu ki n-6 in im mu ni ty, in fl am ma tion and can cer. Tren ds Mol Med 2008;14:109-19.
  87. Pal R, Ja nz M, Gal son DL, Gries M, Li S, Joh re ns K, et al. C/ EBPbeta re gu la tes tran scrip tion fac to rs cri ti cal for pro- li fe ra tion and sur vi val of mul tip le mye lo ma cel ls. Blood 2009;114:3890-8.
  88. Naug ler WE, Sa ku rai T, Kim S, Mae da S, Kim K, El shar kawy AM, Ka rin M. Gen der dis pa ri ty in li ver can cer due to sex dif- fe ren ces in MyD88-de pen de nt IL-6 pro duc tion. Scien ce 2007;317:121-4.
  89. Ra ko ff -Na houm S, Med zhi tov R. Re gu la tion of spon ta- neous in tes ti nal tu mo ri ge ne sis throu gh the adap tor pro- tein MyD88. Scien ce 2007;317:124-7.
  90. Gao SP, Ma rk KG, Les lie K, Pao W, Mo toi N, Ge ra ld WL, et al. Mu ta tio ns in the EGFR ki na se do main me dia te STA T3 ac- ti va tion via IL-6 pro duc tion in hu man lu ng ade no car ci no- mas. J Clin In ve st 2007;117:3846-56.
  91. Gri ven ni kov S, Ka rin M. Au toc ri ne IL-6 sig na li ng: a key eve- nt in tu mo ri ge ne sis? Can cer Ce ll 2008;13:7-9.
  92. San so ne P, Stor ci G, Ta vo la ri S, Guar nie ri T, Gio van ni ni C, Taff u rel li M, et al. IL-6 trig ge rs ma lig na nt fea tu res in mam- mos phe res from hu man duc tal brea st car ci no ma and nor- mal mam ma ry gla nd. J Clin In ve st 2007;117:3988-4002.
  93. Bol lra th J, Phes se TJ, von Bur stin VA, Pu toc zki T, Ben nec ke M, Ba te man T, et al. gp130-me dia ted Sta t3 ac ti va tion in en te ro cytes re gu la tes ce ll sur vi val and ce ll-cycle prog res- sion du ri ng co li ti s-as so cia ted tu mo ri ge ne sis. Can cer Ce ll 2009;15:91-102.
  94. Gri ven ni kov S, Ka rin E, Ter zic J, Mu ci da D, Yu GY, Val lab ha- pu ra pu S, et al. IL-6 and Sta t3 are requi red for sur vi val of in- tes ti nal epit he lial cel ls and de ve lop me nt of co li ti s-as so cia- ted can cer. Can cer Ce ll 2009;15:103-13.
  95. Kor tylewski M, Xin H, Ku jawski M, Lee H, Liu Y, Har ris T, et al. Re gu la tion of the IL-23 and IL-12 ba lan ce by Sta t3 sig na li ng in the tu mor mic roen vi ron me nt. Can cer Ce ll 2009;15:114-23.
  96. Bal kwi ll F. Can cer and the che mo ki ne ne two rk. Nat Rev Can cer 2004;4:540-50.
  97. La zen nec G, Ric hmo nd A. Che mo ki nes and che mo ki ne re- cep to rs: new in sig hts in to can ce r-re la ted in fl am ma tion. Tren ds Mol Med 2010;16:133-44.
  98. Nib bs RJ, Gil chri st DS, Ki ng V, Fer ra A, For row S, Hun ter KD, Gra ham GJ. The atypi cal che mo ki ne re cep tor D6 sup pres- ses the de ve lop me nt of che mi cal ly in duced skin tu mo rs. J Clin In ve st 2007;117:1884-92.

Authors
Del Prete, A., Allavena, P., Santoro, G., Fumarulo, R., Corsi, M. M., & Mantovani, A.
Affiliations
  • IRCCS Humanitas Research Hospital (IT)
  • University of Bari Aldo Moro (IT)
  • University of Milan (IT)
ORCID
Venue
Biochemia Medica
Publisher
Croatian Society for Medical Biochemistry and Laboratory Medicine
Published
2011
Volume
21
Issue
3
Pages
264-275
ISSN
  • 1330-0962 (ISSN-L)
  • 1846-7482
DOI
10.11613/bm.2011.036
OpenAlex
W2090098587
Cited by
181
References
22
Citations by year
2026: 4 · 2025: 4 · 2024: 15 · 2023: 12 · 2022: 11 · 2021: 15 · 2020: 16 · 2019: 15 · 2018: 18 · 2017: 11 · 2016: 18 · 2015: 13 · 2014: 12 · 2013: 14 · 2012: 2
FWCI
0.81
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Biochemia Medica (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Zagreb University Computing Centre (SRCE) (submittedVersion, other-oa)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, other-oa)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
Keywords
tumor inflammation, tumor microenvironment, NF-κB signaling, chronic inflammation, tumor-associated macrophages, cytokines and chemokines, angiogenesis, metastasis, immune evasion, genomic instability, carcinogenesis, therapeutic target, biomarkers, chemoprevention, chemosensitization, tumor suppressor, oncogenes
MeSH terms
Animals, Humans, Inflammation, Models, Biological, Neoplasms, Oncogenes, Risk Factors, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review